tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Taylor, 174 are a BUY (59.79%), 94 are a HOLD (32.3%), 23 are a SELL (7.9%).
Analyst Matthew Taylor, currently employed at JEFFERIES, carries an average stock price target met ratio of 64.29% that have a potential upside of 20.27% achieved within 201 days.
Matthew Taylor’s has documented 581 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 28-Jul-2026.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jan-2017
$135
$37.5 (38.46%)
$135
29 days ago
(08-Sep-2026)
23/35 (65.71%)
$29.48 (27.94%)
340
Hold Since 13-Aug-2026
$130
$32.5 (33.33%)
1 months 24 days ago
(13-Aug-2026)
2/3 (66.67%)
$18.73 (16.83%)
29
Buy Since 28-Jul-2026
$125
$27.5 (28.21%)
$117
2 months 9 days ago
(28-Jul-2026)
3/4 (75%)
$17.73 (16.53%)
150
Buy Since 06-Jun-2019
$112
$14.5 (14.87%)
$136
2 months 20 days ago
(17-Jul-2026)
21/29 (72.41%)
$11.32 (11.24%)
409
Buy Since 19-Sep-2024
$118
$20.5 (21.03%)
$115
2 months 20 days ago
(17-Jul-2026)
4/8 (50%)
$17.32 (17.20%)
120
Which stock is Matthew Taylor most bullish on?
Which stock is Matthew Taylor most reserved on?
What Year was the first public recommendation made by Matthew Taylor?
